Transfer of neuropathogenic simian immunodeficiency virus with naturally infected microglia

D Watry1, T E Lane, M Streb

  • 1Department of Neuropharmacology, Scipps Research Institute, La Jolla, California 92037, USA.

Insights

Certain simian immunodeficiency virus (SIV) variants infect the central nervous system (CNS), causing dementia. This study shows SIV-infected microglia from rhesus monkeys can transfer CNS infection, revealing neuropathogenic viral elements.

Area of Science:

  • Neurovirology
  • Immunology
  • Pathology

Background:

  • The human immunodeficiency virus (HIV) targets the central nervous system (CNS), leading to dementia in acquired immune deficiency syndrome (AIDS).
  • Specific viral variants are implicated in CNS invasion, infecting microglia and brain macrophages.

Purpose of the Study:

  • To investigate if viruses entering the CNS exhibit particular neuropathogenicity.
  • To determine if simian immunodeficiency virus (SIV)-infected microglia can transfer CNS infection.

Main Methods:

  • Isolation of microglia from SIV-infected rhesus monkey brains.
  • Serial transfer of isolated microglia into naive animals to assess infection transfer.
  • Monitoring for CNS infection, viral gene expression, and neuropathology.

Main Results:

  • Productive SIV infection was transferable via isolated microglia.
  • CNS infection was established rapidly following microglia transfer.
  • SIV infection was associated with viral gene expression and pathology resembling HIV encephalitis.

Conclusions:

  • Neuropathogenic SIV variants selectively accumulate within the CNS.
  • This model facilitates the study of functional neuropathogenic viral elements responsible for CNS disease.

Related Concept Videos